Verastem (VSTM) Non-Current Debt (2017 - 2026)
Verastem's (VSTM) quarterly Non-Current Debt came in at $73.1 million in Q1 2026, up 2.3% year-on-year from $71.5 million in Q1 2025, and down 4.21% quarter-over-quarter from $76.3 million in Q4 2025.
Verastem (VSTM) Non-Current Debt (2017 - 2026) Analysis & Trends
Verastem's Non-Current Debt history runs 9 years deep, the most recent figure standing at $73.1 million for Q1 2026.
- On a quarterly basis, Non-Current Debt rose 2.3% year-over-year to $73.1 million in Q1 2026; TTM through Mar 2026 was $73.1 million, a 2.3% increase from a year earlier, with the FY2025 full-year figure at $76.3 million, up 87.43% from the prior year.
- Non-Current Debt fell to $73.1 million in Q1 2026 per VSTM's latest filing, from $76.3 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $78.1 million in Q3 2025 and bottomed at $24.2 million in Q1 2022.
- The 5-year median for Non-Current Debt is $39.9 million (2023), against an average of $45.7 million.
- Across the five-year window, Non-Current Debt slipped 23.21% in 2024 and jumped 154.92% in 2025, its largest moves.
- Year by year, Non-Current Debt stood at $24.5 million in 2022, then jumped by 63.44% to $40.1 million in 2023, then increased by 1.59% to $40.7 million in 2024, then soared by 87.43% to $76.3 million in 2025, then dropped by 4.21% to $73.1 million in 2026.
- Per Business Quant, the three latest VSTM Non-Current Debt figures stand at $73.1 million (Q1 2026), $76.3 million (Q4 2025), and $78.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 105.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 842.92 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Verastem | 166.09 Mn | -31.73 Mn | 15.90 Mn | 73.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 73.12 Mn |
| Dec 31, 2025 | 76.33 Mn |
| Sep 30, 2025 | 78.12 Mn |
| Jun 30, 2025 | 74.27 Mn |
| Mar 31, 2025 | 71.48 Mn |
| Dec 31, 2024 | 40.72 Mn |
| Sep 30, 2024 | 30.65 Mn |
| Jun 30, 2024 | 35.39 Mn |
| Mar 31, 2024 | 40.12 Mn |
| Dec 31, 2023 | 40.09 Mn |
| Sep 30, 2023 | 39.91 Mn |
| Jun 30, 2023 | 39.74 Mn |
| Mar 31, 2023 | 39.57 Mn |
| Dec 31, 2022 | 24.53 Mn |
| Sep 30, 2022 | 24.40 Mn |
| Jun 30, 2022 | 24.28 Mn |
| Mar 31, 2022 | 24.16 Mn |
| Sep 30, 2020 | 35.70 Mn |
| Jun 30, 2020 | 35.50 Mn |
| Mar 31, 2020 | 35.30 Mn |